Testosterone topical - Ferring

Drug Profile

Testosterone topical - Ferring

Alternative Names: FE-999303; Testavan; Testavance

Latest Information Update: 13 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ferring Pharmaceuticals
  • Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Eye disorder therapies; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Hypogonadism

Most Recent Events

  • 13 Jan 2016 Preregistration for Hypogonadism in USA before January 2016 (Topical) (Ferring pipeline, January 2016)
  • 01 Jun 2015 Ferring Pharmaceuticals completes a phase III trial for Hypogonadism in USA (NCT02149264)
  • 30 Mar 2015 Ferring Pharmaceuticals completes enrolment in a phase III trial for Hypogonadism in USA (NCT02149264)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top